SLILATY STEVE N. (Chief Executive Officer) purchased 200.0% of their position (20K shares) of SUNSHINE BIOPHARMA INC. on the open market
Open‑market purchase worth $2.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/12/2024ACC: 0001683168-24-000879
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+20K
Net shares
Net buyer
$2.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Series B Preferred Stock
Direct
Shares
+20K
Price / share
$0.10
Trade value
$2K
% of position
200.0%
2/8/2024
10K→30K
Total
Net shares
+20K
Net value
$2K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | 2/8/2024 | P · Purchase | +20K | $0.10 | $2K | 200.0% | 10K | 30K |
| Total | +20K | $2K | ||||||
Derivative Transactions0
No derivative transactions reported